glucagon like peptide 1 glp 1 agonists glp-1_analogs [TUSOM Glucagon-like peptide 1 in health

This helps to increase insulin release after eating, lower glucagon levels, and slow down the emptying of the stomach, all of which contribute to improved blood sugar levels

Researchers are exploring whether GLP-1 medications used for diabetes and weight loss could treat Alzheimers and addiction.

and in July 2024, the FDA approved Kisunla (donanemab) for early symptomatic Alzheimers, based on evidence of reduced clinical decline and a limitedduration regimen tied to amyloid plaque removal

Once weekly subcutaneous injection, gradually titrated by your provider

This study demonstrated that the long-acting GLP-1R agonist, NLY01, has different health benefits in two different mouse models of MS